Related Experiment Videos
Spontaneous cervical carotid artery dissection: outpatient treatment with continuous heparin infusion using a totally
Neurosurgery
|January 1, 1981
Insights
This study details a successful treatment for spontaneous internal carotid artery dissection using continuous intravenous heparin. The therapy, administered via an implantable device for five months, resolved severe ischemic deficits.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Cardiology
Background:
- Spontaneous internal carotid artery dissection is a rare but serious condition.
- Cervical artery dissection can lead to severe ischemic deficits.
- Reversible ischemic neurological deficits require prompt and effective management.
Purpose of the Study:
- To present a case of spontaneous high cervical internal carotid artery dissection.
- To describe the successful treatment of severe reversible ischemic deficit.
- To detail the use of continuous intravenous heparin therapy via an implantable infusion device.
Main Methods:
- A patient with spontaneous high cervical internal carotid artery dissection and severe reversible ischemic deficit was treated.
- Continuous intravenous heparin was administered for 5 months.
- An implantable infusion device was utilized for heparin delivery.
Main Results:
- The treatment with continuous intravenous heparin was successful.
- The patient's severe reversible ischemic deficit resolved.
- The use of an implantable infusion device facilitated long-term heparin therapy.
Conclusions:
- Continuous intravenous heparin therapy is an effective treatment for spontaneous internal carotid artery dissection with reversible ischemic deficit.
- Implantable infusion devices offer a viable option for long-term anticoagulation therapy in managing such conditions.
- This case highlights the importance of considering anticoagulation and specialized delivery systems for complex cervical artery dissections.
Abstract:
The authors report a patient with spontaneous high cervical internal carotid artery dissection and a severe reversible ischemic deficit. Successful treatment consisted of 5 months of continuous intravenous heparin using an implantable infusion device. The details of this therapy are described, and alternative therapeutic modalities are discussed.